A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease (Q35975889)

11 August 2017

A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease (English)

1 reference

11 August 2017

1 reference

Ekert H

1

1 reference

11 August 2017

Fok T

2

1 reference

11 August 2017

Dalla-Pozza L

3

1 reference

11 August 2017

Waters K

4

1 reference

11 August 2017

Smith P

5

1 reference

11 August 2017

White L

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

67

1 reference

11 August 2017

1

1 reference

11 August 2017

159-162

1 reference

VP16-213 (etoposide). A critical review of its activity

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Chemotherapy and irradiation in childhood Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Report of the Committee on Hodgkin's Disease Staging Classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Etoposide (VP-16-213). Current status of an active anticancer drug

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

The use of chemotherapy in the treatment of Hodgkin's disease.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

The evolving role of etoposide in the management of lymphomas and Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Male gonadal function after chemotherapy for solid tumors in childhood

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Phase II study of cis-dischlorodiammineplatinum(II) in stage IVB Hodgkin's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968223

Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7678978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reporting outcomes in Hodgkin's disease and lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7678978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1993.28

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

7678978

1 reference